Serum Institute Files ₹100 Cr Defamation Case Against Volunteer Claiming Vaccine Made Him Sick

Supported by

The Serum Institute of India (SII) on Sunday filed a 100 crores defamation suit against the participant, who claimed to suffer neurological and psychological damage as a result of taking the institute’s COVID-19 vaccine ‘Covishield’ dose.

The 40-year-old Chennai-based volunteer of the vaccine had earlier sued the company claiming a ‘virtual neurological breakdown’, and sought ₹5 crores as compensation. The law firm representing the participant had sent a legal notice to SII and the drug regulatory authority.

In its official statement, the company rejected all the allegations, stating they are ‘malicious and misconceived.’ The company is sympathetic to the volunteer’s medical condition, but there is no correlation with the vaccine trial and his illness.

The company further said the medical team specifically informed the volunteer that the complications he suffered were independent of the vaccine trial he underwent. ‘Despite specifically being made aware of the same, he still chose to go public and malign the reputation of the company,’ India Today reported.

SII also filed a criminal case against the volunteer. A senior official from the company told the media that the volunteer had recovered, and the claims were post-meditated attempt to extort the money.

The matter is being investigated by the Drugs Controller General of India and the institutional ethics committee.

The company has partnered with British drugmaker AstraZeneca and the University of Oxford to conduct ‘Covishield’ trials.

Copies of the legal notice by the volunteer were also sent to the UK Chief Executive of AstraZeneca, Chief Investigator of the Oxford trials and Vice-Chancellor of Sri Ramachandra Institute in Chennai, where the participant was administered with the drug.

Also Read: Cop Dragged On Bonnet Of Speeding Car For Half Kilometre In Nagpur

#PoweredByYou We bring you news and stories that are worth your attention! Stories that are relevant, reliable, contextual and unbiased. If you read us, watch us, and like what we do, then show us some love! Good journalism is expensive to produce and we have come this far only with your support. Keep encouraging independent media organisations and independent journalists. We always want to remain answerable to you and not to anyone else.

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

Amplified by

P&G Shiksha

P&G Shiksha Turns 20 And These Stories Say It All

Amplified by

Isha Foundation

Sadhguru’s Meditation App ‘Miracle of Mind’ Hits 1 Million Downloads in 15 Hours, Surpassing ChatGPT’s Early Growth

Recent Stories

Trump Says BRICS Nations Including India Will Face 10% US Tariff Citing Dollar Threat After Bloc Summit

Nepal Flash Floods Kill 7, Wash Away Key Bridge Near China Border; Dozens Missing Amid Heavy Rains

35-Year-Old Woman Gang-Raped on Train in Haryana, Loses Leg After Being Thrown onto Tracks

Contributors

Writer : 
Editor : 
Creatives :